Angiogenesis, thrombospondin-1 and cervical carcinogenesis

Ming Ping Wu, Cheng Yang Chou

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

Original languageEnglish
Pages (from-to)128-138
Number of pages11
JournalTaiwanese Journal of Obstetrics and Gynecology
Volume44
Issue number2
Publication statusPublished - Jun 2005
Externally publishedYes

Fingerprint

Thrombospondin 1
Angiogenesis Inhibitors
Carcinogenesis
Neoplasms
Drug Therapy
Neoplasm Genes
Cellular Structures
Microvessels
Epigenomics
Uterine Cervical Neoplasms
Extracellular Matrix
Endothelial Cells
Growth
Research

Keywords

  • Angiogenesis activator
  • Angiogenesis inhibitor
  • Cervical cancer
  • Metronomic chemotherapy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Angiogenesis, thrombospondin-1 and cervical carcinogenesis. / Wu, Ming Ping; Chou, Cheng Yang.

In: Taiwanese Journal of Obstetrics and Gynecology, Vol. 44, No. 2, 06.2005, p. 128-138.

Research output: Contribution to journalReview article

Wu, Ming Ping ; Chou, Cheng Yang. / Angiogenesis, thrombospondin-1 and cervical carcinogenesis. In: Taiwanese Journal of Obstetrics and Gynecology. 2005 ; Vol. 44, No. 2. pp. 128-138.
@article{f3e4038265794ac4819e1a785b747db6,
title = "Angiogenesis, thrombospondin-1 and cervical carcinogenesis",
abstract = "Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or {"}metronomic{"} chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.",
keywords = "Angiogenesis activator, Angiogenesis inhibitor, Cervical cancer, Metronomic chemotherapy",
author = "Wu, {Ming Ping} and Chou, {Cheng Yang}",
year = "2005",
month = "6",
language = "English",
volume = "44",
pages = "128--138",
journal = "Taiwanese Journal of Obstetrics and Gynecology",
issn = "1028-4559",
publisher = "臺灣婦產科醫學會",
number = "2",

}

TY - JOUR

T1 - Angiogenesis, thrombospondin-1 and cervical carcinogenesis

AU - Wu, Ming Ping

AU - Chou, Cheng Yang

PY - 2005/6

Y1 - 2005/6

N2 - Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

AB - Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

KW - Angiogenesis activator

KW - Angiogenesis inhibitor

KW - Cervical cancer

KW - Metronomic chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=22144455375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144455375&partnerID=8YFLogxK

M3 - Review article

VL - 44

SP - 128

EP - 138

JO - Taiwanese Journal of Obstetrics and Gynecology

JF - Taiwanese Journal of Obstetrics and Gynecology

SN - 1028-4559

IS - 2

ER -